These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 31526871)
1. Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis. Wu R; Mei X; Ye Y; Xue T; Wang J; Sun W; Lin C; Xue R; Zhang J; Xu D Pharmacol Res; 2019 Dec; 150():104454. PubMed ID: 31526871 [TBL] [Abstract][Full Text] [Related]
2. Zn(ii)-Curcumin supplementation alleviates gut dysbiosis and zinc dyshomeostasis during doxorubicin-induced cardiotoxicity in rats. Wu R; Mei X; Wang J; Sun W; Xue T; Lin C; Xu D Food Funct; 2019 Sep; 10(9):5587-5604. PubMed ID: 31432062 [TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-hepatoma effect of a novel curcumin analog C086 Deng Y; Chen C; Xiao Z; Huang X; Xu J Drug Deliv; 2020 Dec; 27(1):927-937. PubMed ID: 32597247 [TBL] [Abstract][Full Text] [Related]
4. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo. Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765 [TBL] [Abstract][Full Text] [Related]
5. Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5-fluorouracil in vivo by increasing curcumin bioavailability. Jin M; Kong L; Han Y; Zhang S Phytother Res; 2021 Oct; 35(10):5823-5837. PubMed ID: 34374130 [TBL] [Abstract][Full Text] [Related]
6. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Hu B; Sun D; Sun C; Sun YF; Sun HX; Zhu QF; Yang XR; Gao YB; Tang WG; Fan J; Maitra A; Anders RA; Xu Y Biochem Biophys Res Commun; 2015 Dec; 468(4):525-32. PubMed ID: 26482853 [TBL] [Abstract][Full Text] [Related]
7. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma. Guo L; Li H; Fan T; Ma Y; Wang L Life Sci; 2021 Aug; 279():119359. PubMed ID: 33753114 [TBL] [Abstract][Full Text] [Related]
8. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771 [TBL] [Abstract][Full Text] [Related]
9. Overuse of antianaerobic drug is associated with poor postchemotherapy prognosis of patients with hepatocellular carcinoma. Iida N; Mizukoshi E; Yamashita T; Terashima T; Arai K; Seishima J; Kaneko S Int J Cancer; 2019 Nov; 145(10):2701-2711. PubMed ID: 30980680 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175 [TBL] [Abstract][Full Text] [Related]
11. Dual-Drug Loaded Nanobubbles Combined with Sonodynamic and Chemotherapy for Hepatocellular Carcinoma Therapy. Guo T; Wang Y; Chen D; Cui S; Guo S; Feng Y; Zhu J; Chang L; Zhang J; Gao X; Wei X Int J Nanomedicine; 2024; 19():7367-7381. PubMed ID: 39050872 [TBL] [Abstract][Full Text] [Related]
12. Zn(II)-curcumin prevents cadmium-aggravated diabetic nephropathy by regulating gut microbiota and zinc homeostasis. Sun W; Mei X; Wang J; Mai Z; Xu D Front Pharmacol; 2024; 15():1411230. PubMed ID: 38903987 [No Abstract] [Full Text] [Related]
13. Bacterial magnetosomes loaded with doxorubicin and transferrin improve targeted therapy of hepatocellular carcinoma. Wang J; Geng Y; Zhang Y; Wang X; Liu J; Basit A; Miao T; Liu W; Jiang W Nanotheranostics; 2019; 3(3):284-298. PubMed ID: 31423412 [TBL] [Abstract][Full Text] [Related]
14. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice. Nasr M; Selima E; Hamed O; Kazem A Eur J Pharmacol; 2014 Jan; 723():267-75. PubMed ID: 24291100 [TBL] [Abstract][Full Text] [Related]
15. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets. Baghbani F; Moztarzadeh F Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome. Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566 [TBL] [Abstract][Full Text] [Related]
18. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells. Abdallah FM; Helmy MW; Katary MA; Ghoneim AI Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693 [TBL] [Abstract][Full Text] [Related]
19. Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma. Zhang S; Tang D; Zang W; Yin G; Dai J; Sun YU; Yang Z; Hoffman RM; Guo X Anticancer Res; 2017 Feb; 37(2):465-473. PubMed ID: 28179291 [TBL] [Abstract][Full Text] [Related]
20. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model. Abdel-Hamid NI; El-Azab MF; Moustafa YM Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]